Eastman Kodak’s potentially lucrative deal to help the U.S. government make more generic drugs domestically is threatening to turn into a regulatory headache for the fallen photography giant. Kodak’s depressed … Click to Continue »
Read more here:: Questions being raised after Kodak’s stock has a big moment
